Sox9 and Sox8 protect the adult testis from male-to-female genetic reprogramming and complete degeneration

  1. Francisco J Barrionuevo
  2. Alicia Hurtado
  3. Gwang-Jin Kim
  4. Francisca M Real
  5. Mohammed Bakkali
  6. Janel L Kopp
  7. Maike Sander
  8. Gerd Scherer
  9. Miguel Burgos
  10. Rafael Jiménez  Is a corresponding author
  1. Universidad de Granada, Spain
  2. University of Granada, Spain
  3. University of Freiburg, Germany
  4. Max Planck Institute for Molecular Genetics, Germany
  5. University of California, San Diego, United States

Abstract

The new concept of mammalian sex maintenance establishes that particular key genes must remain active in the differentiated gonads to avoid genetic sex reprogramming, as described in adult ovaries after Foxl2 ablation. Dmrt1 plays a similar role in postnatal testes, but the mechanism of adult testis maintenance remains mostly unknown. Sox9 and Sox8 are required for postnatal male fertility, but their role in the adult testis has not been investigated. Here we show that after ablation of Sox9 in Sertoli cells of adult, fertile Sox8-/- mice, testis-to-ovary genetic reprogramming occurs and Sertoli cells transdifferentiate into granulosa-like cells. The process of testis regression culminates in complete degeneration of the seminiferous tubules, which become acellular, empty spaces among the extant Leydig cells. DMRT1 protein only remains in non-mutant cells, showing that SOX9/8 maintain Dmrt1 expression in the adult testis. Also, Sox9/8 warrant testis integrity by controlling the expression of structural proteins and protecting Sertoli cells from early apoptosis. Concluding, this study shows that, in addition to its crucial role in testis development, Sox9, together with Sox8 and coordinately with Dmrt1, also controls adult testis maintenance.

Article and author information

Author details

  1. Francisco J Barrionuevo

    Departamento de Genética e Instituto de Biotecnología, Universidad de Granada, Granada, Spain
    Competing interests
    The authors declare that no competing interests exist.
  2. Alicia Hurtado

    Departamento de Genética e Instituto de Biotecnología, University of Granada, Granada, Spain
    Competing interests
    The authors declare that no competing interests exist.
  3. Gwang-Jin Kim

    Institute of Human Genetics, University of Freiburg, Freiburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Francisca M Real

    Max Planck Institute for Molecular Genetics, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Mohammed Bakkali

    Departamento de Genética, Facultad de Ciencias, Universidad de Granada, Granada, Spain
    Competing interests
    The authors declare that no competing interests exist.
  6. Janel L Kopp

    Department of Pediatrics and Cellular and Molecular Medicine, University of California, San Diego, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Maike Sander

    Department of Pediatrics and Cellular and Molecular Medicine, University of California, San Diego, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Gerd Scherer

    Institute of Human Genetics, University of Freiburg, Freiburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Miguel Burgos

    Departamento de Genética e Instituto de Biotecnología, Universidad de Granada, Granada, Spain
    Competing interests
    The authors declare that no competing interests exist.
  10. Rafael Jiménez

    Departamento de Genética e Instituto de Biotecnología, Universidad de Granada, Granada, Spain
    For correspondence
    rjimenez@ugr.es
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Janet Rossant, University of Toronto, Canada

Ethics

Animal experimentation: This study was performed in strict accordance with the guidelines for the protection of the animals used in scientific experimentation (Decree-Law 53/2013), dictated by the Spanish Ministry of Presidency. The protocol was approved by the Ethical Committee for Animal Experimentation of theUniversity of Granada (Ref. No.: 123-CEEA-UGR-2011). All surgery, except the BTB permeability experiment, was performed post-mortem after cervical dislocation. BTB experiment was performed under anesthesia for 30 min and then the animals were sacrificed without recovery. Every effort was made to minimize suffering.

Version history

  1. Received: February 29, 2016
  2. Accepted: June 7, 2016
  3. Accepted Manuscript published: June 21, 2016 (version 1)
  4. Version of Record published: July 14, 2016 (version 2)

Copyright

© 2016, Barrionuevo et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 8,118
    views
  • 748
    downloads
  • 72
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Francisco J Barrionuevo
  2. Alicia Hurtado
  3. Gwang-Jin Kim
  4. Francisca M Real
  5. Mohammed Bakkali
  6. Janel L Kopp
  7. Maike Sander
  8. Gerd Scherer
  9. Miguel Burgos
  10. Rafael Jiménez
(2016)
Sox9 and Sox8 protect the adult testis from male-to-female genetic reprogramming and complete degeneration
eLife 5:e15635.
https://doi.org/10.7554/eLife.15635

Share this article

https://doi.org/10.7554/eLife.15635

Further reading

    1. Developmental Biology
    2. Medicine
    Stephen E Flaherty III, Olivier Bezy ... Zhidan Wu
    Research Article

    From a forward mutagenetic screen to discover mutations associated with obesity, we identified mutations in the Spag7 gene linked to metabolic dysfunction in mice. Here, we show that SPAG7 KO mice are born smaller and develop obesity and glucose intolerance in adulthood. This obesity does not stem from hyperphagia, but a decrease in energy expenditure. The KO animals also display reduced exercise tolerance and muscle function due to impaired mitochondrial function. Furthermore, SPAG7-deficiency in developing embryos leads to intrauterine growth restriction, brought on by placental insufficiency, likely due to abnormal development of the placental junctional zone. This insufficiency leads to loss of SPAG7-deficient fetuses in utero and reduced birth weights of those that survive. We hypothesize that a ‘thrifty phenotype’ is ingrained in SPAG7 KO animals during development that leads to adult obesity. Collectively, these results indicate that SPAG7 is essential for embryonic development and energy homeostasis later in life.

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine
    Nikola Sekulovski, Jenna C Wettstein ... Kenichiro Taniguchi
    Research Article

    Amniogenesis, a process critical for continuation of healthy pregnancy, is triggered in a collection of pluripotent epiblast cells as the human embryo implants. Previous studies have established that bone morphogenetic protein (BMP) signaling is a major driver of this lineage specifying process, but the downstream BMP-dependent transcriptional networks that lead to successful amniogenesis remain to be identified. This is, in part, due to the current lack of a robust and reproducible model system that enables mechanistic investigations exclusively into amniogenesis. Here, we developed an improved model of early amnion specification, using a human pluripotent stem cell-based platform in which the activation of BMP signaling is controlled and synchronous. Uniform amniogenesis is seen within 48 hr after BMP activation, and the resulting cells share transcriptomic characteristics with amnion cells of a gastrulating human embryo. Using detailed time-course transcriptomic analyses, we established a previously uncharacterized BMP-dependent amniotic transcriptional cascade, and identified markers that represent five distinct stages of amnion fate specification; the expression of selected markers was validated in early post-implantation macaque embryos. Moreover, a cohort of factors that could potentially control specific stages of amniogenesis was identified, including the transcription factor TFAP2A. Functionally, we determined that, once amniogenesis is triggered by the BMP pathway, TFAP2A controls the progression of amniogenesis. This work presents a temporally resolved transcriptomic resource for several previously uncharacterized amniogenesis states and demonstrates a critical intermediate role for TFAP2A during amnion fate specification.